Oaktree Acquisition Corp. III Life Sciences

Oaktree Acquisition Corp. III Life Sciences (Nasdaq: OACC) is a blank-check company sponsored by an affiliate of Oaktree Capital Management, the global alternative investment firm headquartered in Los Angeles. The vehicle filed an amended S-1 registration statement with the SEC on October 18, 2024, advancing its IPO registration with a stated focus on the life sciences sector, encompassing biopharmaceuticals, medical devices, and diagnostics. The "III" designation marks it as the third SPAC vehicle in Oaktree's acquisition series, underscoring the firm's sustained presence in the blank-check space. For full filing history, deal timelines, and target analytics on OACC, sign up for complete access at SpacDesk.